Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

Invasive breast cancer shows a wide range of morphological differentiation, associated with differences in prognosis, but as yet, the underlying genetic mechanisms cannot be accounted for. In order to establish a model of the possible progression from the different subtypes of ductal carcinoma in situ (DCIS) to invasive breast cancer, 77 selected cases of invasive breast cancer representing distinct morphological subtypes were investigated by means of comparative genomic hybridization (CGH). There was a high degree of genetic homology between tubular and tubulo‐lobular carcinoma and well‐differentiated DCIS, and between ductal invasive carcinoma G3 and poorly differentiated DCIS. Highly differentiated invasive breast cancers were characterized by a loss of 16q and a low average number of aberrations per case. In high‐grade tumours, losses of this chromosomal region were seen with a much lower frequency in cases with evidence of an aneuploid tumour status. These data demonstrate the close genetic similarity of well‐, intermediately, and poorly differentiated DCIS and distinct morphological types of invasive breast carcinoma, providing further evidence that DCIS is a direct precursor lesion of invasive breast cancer and that various evolutionary genetic pathways exist. Copyright © 1999 John Wiley & Sons, Ltd.

[1]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[2]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[3]  F. Lampert,et al.  COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY , 1997, The Journal of pathology.

[4]  B. Dutrillaux,et al.  Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.

[5]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[6]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.

[7]  Y. Nakamura,et al.  Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. , 1994, Cancer research.

[8]  C. Theillet,et al.  Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. , 1997, Cancer research.

[9]  F. Speleman,et al.  Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer , 1997, Virchows Archiv.

[10]  C. Larsson,et al.  Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. , 1993, Cancer research.

[11]  J Isola,et al.  Genetic alterations in lobular breast cancer by comparative genomic hybridization , 1997, International journal of cancer.

[12]  P. Devilee,et al.  At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer , 1994, Genes, chromosomes & cancer.

[13]  A. Zetterberg,et al.  Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. , 1995, Cancer research.

[14]  C. Poremba,et al.  Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways , 1999, The Journal of pathology.

[15]  S. Hirohashi,et al.  Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. , 1997, The American journal of pathology.

[16]  R. Simon,et al.  Chromosomal aberrations associated with invasion in papillary superficial bladder cancer , 1998 .

[17]  P. Carroll,et al.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. , 1994, The American journal of pathology.

[18]  G. Peters,et al.  Chromosome 11q13 abnormalities in human breast cancer. , 1993, Cancer surveys.

[19]  M. J. van de Vijver,et al.  Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.

[20]  M. Stratton.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[21]  J. Overgaard,et al.  Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. , 1998, Cancer research.

[22]  J. Berg,et al.  TUMORS of the breast. I. , 1954, Medical times.

[23]  S. Hilsenbeck,et al.  Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.

[24]  P. V. van Diest,et al.  Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors , 1998, The Journal of pathology.

[25]  N. Sneige,et al.  Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. , 1991, Archives of pathology & laboratory medicine.

[26]  S. Hirohashi,et al.  Detection of allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens. , 1996, Acta cytologica.